Presenter: Dr. Christopher Patriquin

CP CET

Dr. Christopher Patriquin completed his MD degree and Internal Medicine residency at the University of Western Ontario. He then attended McMaster University for hematology, where he subsequently stayed on as a Clinical Scholar in complement-mediated disease. His primary clinical interests include the thrombotic microangiopathies (TMA) and paroxysmal nocturnal hemoglobinuria (PNH), and his M.Sc. in health research methodology focused on clinical trial and observational methods for studying rare diseases. In 2015, Dr. Patriquin completed honorary clinical research fellowships in the United Kingdom in TMA (University College London) and PNH (NHS National PNH Service, Leeds).

Dr. Patriquin is a member of the Canadian Apheresis Group’s TMA working group, a member of the American Society for Apheresis TMA Subcommittee, Chair for the Canadian PNH Network, and Canadian national coordinator for the International PNH Registry. In 2018, he joined the University Health Network as Assistant Professor of Medicine, where he is a consultant in hematology and apheresis medicine.

ukidneyisup